Singapore markets closed

SynCore Biotechnology Co.,Ltd (4192.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
43.50-0.15 (-0.34%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 1.53B
Enterprise value 1.30B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)73.55
Price/book (mrq)4.40
Enterprise value/revenue 62.36
Enterprise value/EBITDA -31.74

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-31.72%
S&P500 52-week change 325.87%
52-week high 366.69
52-week low 334.55
50-day moving average 346.38
200-day moving average 341.05

Share statistics

Avg vol (3-month) 351.98k
Avg vol (10-day) 320.4k
Shares outstanding 535.16M
Implied shares outstanding 635.33M
Float 8N/A
% held by insiders 169.30%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2267.16458:1000
Last split date 329 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -132.33%
Operating margin (ttm)-329.12%

Management effectiveness

Return on assets (ttm)-5.63%
Return on equity (ttm)-9.65%

Income statement

Revenue (ttm)20.87M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)18.20%
Gross profit (ttm)N/A
EBITDA -26.74M
Net income avi to common (ttm)-27.62M
Diluted EPS (ttm)-0.79
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)248.42M
Total cash per share (mrq)7.06
Total debt (mrq)14.88M
Total debt/equity (mrq)4.26%
Current ratio (mrq)13.56
Book value per share (mrq)9.93

Cash flow statement

Operating cash flow (ttm)-74.58M
Levered free cash flow (ttm)-69.92M